Are we trumping bone disease in prostate cancer? The Rove/Crawford article reviewed [Evolution of treatment options for patients with CRPC and bone metastases: Bone-targeted agents that go beyond palliation of symptoms to improve overall survival] Journal Article
| Author: | Slovin, S. F. |
| Article Title: | Are we trumping bone disease in prostate cancer? The Rove/Crawford article reviewed [Evolution of treatment options for patients with CRPC and bone metastases: Bone-targeted agents that go beyond palliation of symptoms to improve overall survival] |
| Keywords: | signal transduction; cancer survival; protein expression; osteolysis; unclassified drug; drug tolerability; placebo; cancer combination chemotherapy; cancer growth; drug efficacy; drug safety; nonhuman; bone metastasis; cancer staging; biological marker; prostate specific antigen; bone morphogenetic protein; cancer pain; drug effect; docetaxel; prostate cancer; androgen receptor; clinical effectiveness; radioisotope; cancer control; drug treatment failure; lipocortin 2; analgesia; bone disease; osteoprotegerin; osteoclast differentiation factor; scatter factor receptor; urokinase; castration resistant prostate cancer; bone turnover; stromal cell derived factor 1; amino terminal telopeptide; endothelin 1; osteopontin; radium 223; osteoclast activity; lexidronam samarium sm 153; samarium 153; strontium 89; alkaline phosphatase bone isoenzyme |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 25 |
| Issue: | 14 |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2011-12-01 |
| Start Page: | 1390 |
| End Page: | 1393 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 22329190 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 March 2012" - "CODEN: OCLGE" - "Source: Scopus" |
